UNSPSC 51284119: Ceftriaxone

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75J73V1629. European Medicines Agency schedules Ceftriaxone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07431MIG. Ceftriaxone generally arises in the molecular formula C18H18N8O7S3.

UNSPSC 51284119 Ceftriaxone is a Commodity code representing a specific injectable antibiotic pharmaceutical product. State and local governments procure this drug through cooperative purchasing vehicles and piggyback contracts to supply public health agencies, emergency response programs, and community health initiatives. The code reflects procurement of a branded or generic pharmaceutical line item rather than a broader drug category, with purchases typically bundled into larger pharmaceutical warehouse orders or emergency medical supply agreements.

State and local health departments and county community health programs drive purchasing under this code. Recent activity shows Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 (Solicitation 26482DPHPREPDB53392, IFB process, $2,999,999.11 total contract value over 12 months with renewal options for years 2 and 3), though the specific line items in that award were Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets rather than Ceftriaxone. Seminole County, Florida posted an IFB in June 2026 (IFB60459723LAS, due July 26, 2023) for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries, also demonstrating county-level pharmaceutical and medical supply purchasing through formal bid processes. The code shows limited recent activity tagged directly to Ceftriaxone procurement; vendors should verify whether state and local opportunities under this code actually solicit the antibiotic or whether mislabeling has occurred in the procurement system.